# Viking Therapeutics (VKTX) — News

VKTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vktx/news

## Recent headlines

- [Viking Therapeutics announces initiation of VK2735 oral phase 3 clinical program in patients with obesity](https://www.ainvest.com/news/viking-therapeutics-announces-initiation-vk2735-oral-phase-3-clinical-program-patients-obesity-2610) — AInvest Wire, Oct 14, 2026
- [Viking Therapeutics, Inc.: Truist Securities cuts target price to $85 from $87](https://www.ainvest.com/news/viking-therapeutics-truist-securities-cuts-target-price-85-87-2610) — AInvest Wire, Oct 7, 2026
  Truist Securities has revised its target price for Viking Therapeutics, Inc. (VKTX) to $85 per share, down from the previous $87, while maintaining its "Buy" rating . The adjustment reflects updated analyst assessments of the company’s near-term outlook and market positioning. Despite the reduced…
- [Viking Therapeutics announces initiation of VK2735 oral maintenance dosing clinical trial in patients with obesity](https://www.ainvest.com/news/viking-therapeutics-announces-initiation-vk2735-oral-maintenance-dosing-clinical-trial-patients-obesity-2610) — AInvest Wire, Oct 6, 2026
- [Viking Therapeutics shares down 15% after co prices upsized stock, convertible offerings](https://www.ainvest.com/news/viking-therapeutics-shares-15-prices-upsized-stock-convertible-offerings-2609) — AInvest Wire, Sep 24, 2026
  Viking Therapeutics (Nasdaq: VKTX) announced its intention to raise $200.0 million through a public offering of common stock and an additional $200.0 million in convertible senior notes due 2032, with both offerings registered under the Securities Act of 1933, as amended. The company also granted…
- [Viking Therapeutics, - Offering size increased to $275 mln common stock and $225 mln notes](https://www.ainvest.com/news/viking-therapeutics-offering-size-increased-275-mln-common-stock-225-mln-notes-2609) — AInvest Wire, Sep 24, 2026
  Viking Therapeutics, Inc. (Nasdaq: VKTX) has increased the size of its proposed capital raise, announcing plans to offer $275 million of common stock and $225 million aggregate principal amount of convertible senior notes due 2032, up from the previously announced $200 million each. The company has…

## Similar Stocks

- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [MDGL](https://www.lighthorse.io/tickers/mdgl) — Madrigal Pharmaceuticals, Inc. - Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).